X
HUMIRA
HUMIRA
HUMIRA

HUMIRA (ADALIMUMAB)

Product ID : 43022193
5 out of 5 stars


Galleon Product ID 43022193
Shipping Weight 0.4 lbs
I think this is wrong?
Model
Manufacturer
Shipping Dimension 9.02 x 5.98 x 0.24 inches
I think this is wrong?
-
1,459

*Price and Stocks may change without prior notice
*Packaging of actual item may differ from photo shown
  • Electrical items MAY be 110 volts.
  • 7 Day Return Policy
  • All products are genuine and original
  • Cash On Delivery/Cash Upon Pickup Available

Pay with

About HUMIRA

Humira is a medicine called a tumor necrosis element (TNF) blocker. Humira is used: to lessen the signs and signs of: slight to excessive rheumatoid arthritis (RA) in adults. Humira can be used by myself, with methotrexate, or with positive other drugs. Mild to extreme Crohn’s sickness (CD) in kids 6 years and older while different treatments have now not worked well sufficient. Slight to intense hidradenitis suppurativa (HS) in adults. In adults, to help get mild to intense ulcerative colitis (UC) below manipulate (set off remission) and hold it beneath control (sustain remission) when sure different medicines have not worked properly sufficient. It isn't recognized if humira is powerful in folks that stopped responding to or couldn't tolerate TNF-blocker medicines. To treat mild to severe continual (lasting a long time) plaque psoriasis (PS) in adults who have the condition in many regions of their body and who may additionally gain from taking injections or capsules (systemic therapy) or phototherapy (treatment the usage of ultraviolet light by myself or with capsules). Those instances have had a completely competitive ailment direction and had been fatal. The majority of reported TNF blocker cases have took place in sufferers with crohn's disorder or ulcerative colitis and the majority was in adolescent and young person adult males. Almost some of these patients had obtained remedy with azathioprine or 6-mercaptopurine (6-mp) concomitantly with a TNF blocker at or previous to analysis. It's far unsure whether or not the prevalence of HSTCL is related to use of a TNF blocker or a TNF blocker in combination with those different immunosuppressants. Patients dealt with humira are at multiplied hazard for growing extreme infections related to numerous organ systems and sites which can lead to hospitalization or dying. Opportunistic infections due to bacterial, mycobacterial, invasive fungal, viral, parasitic, or different opportunistic pathogens consisting of aspergillosis, blastomycosis, candidiasis, coccidioidomycosis, histoplasmosis, legionellosis, listeriosis, pneumocystosis and tuberculosis had been pronounced with TNF blockers. Sufferers have regularly offered with disseminated in place of localized disorder. The concomitant use of a TNF blocker and abatacept or anakinra was associated with a better chance of great infections in sufferers with rheumatoid arthritis (RA); therefore, the concomitant use of humira and those biologic products is not endorsed within the treatment of sufferers with RA. Treatment with humira need to no longer be initiated in patients with an active contamination, inclusive of localized infections.